Haemonetics Corp (HAE) returns
Haemonetics returns over 10 years
$1,000 invested in Haemonetics ten years ago was worth $3,610 at the close on October 30, 2026, with dividends reinvested: an average return of 13.7% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +13.6% | — | $1,136 | -0.9% |
| 3 months | +41.1% | — | $1,411 | +2.1% |
| Year to date | +49.3% | — | $1,493 | +11.7% |
| 1 year | +139.3% | — | $2,393 | +12.4% |
| 3 years | +40.9% | +12.1% | $1,409 | +88.5% |
| 5 years | +74.1% | +11.7% | $1,741 | +76.0% |
| 10 years | +261.0% | +13.7% | $3,610 | +316.6% |
Haemonetics return by calendar year
| Year | HAE | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +49.3% | +11.7% | +37.6% |
| 2025 | +2.7% | +17.7% | -15.1% |
| 2024 | -8.7% | +24.9% | -33.6% |
| 2023 | +8.7% | +26.2% | -17.5% |
| 2022 | +48.3% | -18.2% | +66.5% |
| 2021 | -55.3% | +28.7% | -84.1% |
| 2020 | +3.4% | +18.4% | -15.0% |
| 2019 | +14.8% | +31.2% | -16.4% |
| 2018 | +72.3% | -4.6% | +76.8% |
| 2017 | +44.5% | +21.7% | +22.8% |
| 2016 | +24.7% | +12.0% | +12.7% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: HAE financials · HAE valuation
No forecast, no recommendation. This page describes Haemonetics Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.